CMPS
NASD COMPASS Pathways Plc Sponsored ADR$11.60 ↑ +0.04 (+0.31%) Trading Up from the previous close of $11.56
- YTD change
- +68.05%
- vs 20-day SMA
- -14.56%
- vs 200-day SMA
- +16.14%
Price ranges
Price & Performance
+6.02 (+108.66%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 81.2% away from all-time highs of $61.69
- CMPS is up 68% since the beginning of the year
- CMPS is up 86% over the past 12 months
- CMPS is down 17% over the past 1 month
- 12% of all CMPS investors are betting against CMPS
CMPS reads not so good: price sits above one of the two key moving averages, the 12-month move is +85.3%.
- Previous minute
- +$0.00
- Last hour
- -$0.00
- Last 5 days
- -10.53%
- vs 8-day SMA
- -6.02%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.